Treatment Manages CMV in Transplant Recipients
Preemptive ganciclovir treatment of cytomegalovirus (CMV) infection in simultaneous pancreas-kidney (SPK) transplant recipients appears to be associated with good long-term outcomes, German researchers report.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.